Eflapegrastim Provides Superior Neutropenia Control Over Pegfilgrastim in Phase III Breast Cancer Study

KeepHealthCare.ORG – Eflapegrastim Provides Superior Neutropenia Control Over Pegfilgrastim in Phase III Breast Cancer Study Lee S. Schwartzberg, MD, FACP Eflapegrastim (Rolontis), a novel long-acting granulocyte-colony stimulating factor (G-CSF), has Continue reading